• Je něco špatně v tomto záznamu ?

Late open conversion after endovascular abdominal aortic aneurysm repair: experience of three-high volume centers

LB. Davidovic, D. Palombo, V. Treska, M. Sladojevic, IB. Koncar, K. Houdek, G. Spinella, P. Zlatanovic, B. Pane,

. 2020 ; 61 (2) : 183-190. [pub] 20191118

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023087

BACKGROUND: Accumulated endovascular aneurysm repair (EVAR) procedures will increase number of patients requiring conversion to open repair of abdominal aortic aneurysms (AAA). In most cases, patients undergo late open surgical conversion (LOSC), many months, or years, after initial EVAR. The aim of this study is to analyze results of LOSC after EVAR in elective and urgent setting, including presenting features, surgical techniques, as well as to review the clinical outcomes and their predictors. METHODS: Retrospective review of all consecutive patients undergoing LOSC after EVAR was performed at three distinct, high volume, vascular centers. Patients that required primary conversion within 30 days after EVAR have not been included in this study. Between January 1st 2010 and January 1st 2017 total of 31 consecutive patients were treated. LOSC were performed either in elective or in urgent setting, thus dividing patients in two groups. Primary outcome was 30-day mortality and secondary postoperative complications. RESULTS: LOSC rate after EVAR was 4.51%. Most common indication for LOSC was type I endoleak (N.=20, 64.51%). All patients that presented with ruptured AAA had some form of endoleak (type I endoleak was present in five from six cases). Most common site for aortic cross-clamping was infrarenal (51.61%). Stent-graft was removed completely in 18 patients (58.06%) and partially in 13 (41.93%). 30-day mortality rate was 16.12% (5 patients) and most common cause of death was myocardial infarction (60%). Following univariate factors were isolated as predictors for 30-day mortality: preoperative coronary artery disease, chronic obstructive pulmonary disease, urgent LOSC, prolonged time until LOSC, ruptured AAA, supraceliac clamp, higher number of red blood cell transfusion, postoperative myocardial infarction, and prolonged intubation (more than 48 hours). CONCLUSIONS: LOSC seems to be safe and effective procedure when preformed in elective manner. On the other side, urgent LOSC after EVAR is associated with very high postoperative mortality and morbidity. Endoleak remains the main indication for open conversion. Further studies are necessary to standardize timing and treatment options for failing EVAR.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023087
003      
CZ-PrNML
005      
20201214125243.0
007      
ta
008      
201125s2020 it f 000 0|eng||
009      
AR
024    7_
$a 10.23736/S0021-9509.19.10972-X $2 doi
035    __
$a (PubMed)31755677
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Davidovic, Lazar B $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Clinic for Vascular and Endovascular Surgery, Clinical Center of Serbia, Belgrade, Serbia.
245    10
$a Late open conversion after endovascular abdominal aortic aneurysm repair: experience of three-high volume centers / $c LB. Davidovic, D. Palombo, V. Treska, M. Sladojevic, IB. Koncar, K. Houdek, G. Spinella, P. Zlatanovic, B. Pane,
520    9_
$a BACKGROUND: Accumulated endovascular aneurysm repair (EVAR) procedures will increase number of patients requiring conversion to open repair of abdominal aortic aneurysms (AAA). In most cases, patients undergo late open surgical conversion (LOSC), many months, or years, after initial EVAR. The aim of this study is to analyze results of LOSC after EVAR in elective and urgent setting, including presenting features, surgical techniques, as well as to review the clinical outcomes and their predictors. METHODS: Retrospective review of all consecutive patients undergoing LOSC after EVAR was performed at three distinct, high volume, vascular centers. Patients that required primary conversion within 30 days after EVAR have not been included in this study. Between January 1st 2010 and January 1st 2017 total of 31 consecutive patients were treated. LOSC were performed either in elective or in urgent setting, thus dividing patients in two groups. Primary outcome was 30-day mortality and secondary postoperative complications. RESULTS: LOSC rate after EVAR was 4.51%. Most common indication for LOSC was type I endoleak (N.=20, 64.51%). All patients that presented with ruptured AAA had some form of endoleak (type I endoleak was present in five from six cases). Most common site for aortic cross-clamping was infrarenal (51.61%). Stent-graft was removed completely in 18 patients (58.06%) and partially in 13 (41.93%). 30-day mortality rate was 16.12% (5 patients) and most common cause of death was myocardial infarction (60%). Following univariate factors were isolated as predictors for 30-day mortality: preoperative coronary artery disease, chronic obstructive pulmonary disease, urgent LOSC, prolonged time until LOSC, ruptured AAA, supraceliac clamp, higher number of red blood cell transfusion, postoperative myocardial infarction, and prolonged intubation (more than 48 hours). CONCLUSIONS: LOSC seems to be safe and effective procedure when preformed in elective manner. On the other side, urgent LOSC after EVAR is associated with very high postoperative mortality and morbidity. Endoleak remains the main indication for open conversion. Further studies are necessary to standardize timing and treatment options for failing EVAR.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a aneurysma břišní aorty $x diagnostické zobrazování $x mortalita $x chirurgie $7 D017544
650    _2
$a cévy - implantace protéz $x škodlivé účinky $x metody $7 D019917
650    12
$a příčina smrti $7 D002423
650    _2
$a konverze na otevřenou operaci $x metody $x mortalita $7 D061887
650    _2
$a databáze faktografické $7 D016208
650    _2
$a endoleak $x chirurgie $7 D057867
650    _2
$a endovaskulární výkony $x škodlivé účinky $x metody $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mortalita v nemocnicích $7 D017052
650    _2
$a specializovaná centra se zvyšujícím se počtem výkonů a tím zvyšující se kvalitou léčby $7 D061847
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a prognóza $7 D011379
650    _2
$a reoperace $x metody $7 D012086
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Palombo, Domenico $u Unit of Vascular and Endovascular Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.
700    1_
$a Treska, Vladislav $u Department of Surgery, University Hospital, School of Medicine, Pilsen, Czech Republic.
700    1_
$a Sladojevic, Milos $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia - sladojevic@gmail.com. Clinic for Vascular and Endovascular Surgery, Clinical Center of Serbia, Belgrade, Serbia.
700    1_
$a Koncar, Igor B $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Clinic for Vascular and Endovascular Surgery, Clinical Center of Serbia, Belgrade, Serbia.
700    1_
$a Houdek, Karel $u Department of Vascular Surgery, University Hospital Regensburg, Regensburg, Germany.
700    1_
$a Spinella, Giovanni $u Unit of Vascular and Endovascular Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.
700    1_
$a Zlatanovic, Petar $u Clinic for Vascular and Endovascular Surgery, Clinical Center of Serbia, Belgrade, Serbia.
700    1_
$a Pane, Bianca $u Unit of Vascular and Endovascular Surgery, San Martino University Hospital IRCCS, University of Genoa, Genoa, Italy.
773    0_
$w MED00002572 $t The Journal of cardiovascular surgery $x 1827-191X $g Roč. 61, č. 2 (2020), s. 183-190
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31755677 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125242 $b ABA008
999    __
$a ok $b bmc $g 1595406 $s 1113763
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 61 $c 2 $d 183-190 $e 20191118 $i 1827-191X $m Journal of cardiovascular surgery $n J Cardiovasc Surg (Torino) $x MED00002572
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...